NASDAQ, INC. current report, Q1 FY2006

Business Context and Reporting Period

Company: The NASDAQ Stock Market, Inc.
Filing Type: Form 8-K (Current Report)
Reporting Date: February 15, 2006 (Event Date: February 9, 2006)
Context: The registrant entered into a material definitive agreement regarding a public offering of common stock.

Key Financial Metrics

This filing reports on a capital raising event rather than operational performance. Specific metrics include:

  • Gross Proceeds: Approximately $268.7 million expected to be yielded to Nasdaq before expenses.
  • Shares Sold by Nasdaq: 7,000,000 shares of common stock.
  • Shares Sold by Other Stockholders: 6,895,229 shares sold by the National Association of Securities Dealers, Inc. (NASD) and other stockholders.
  • Underwriting Discount: $1.60 per share.
  • Overallotment Option: Underwriters granted an option to purchase up to 2,084,284 additional shares (1,042,142 by Nasdaq, 1,042,142 by NASD) exercisable until March 11, 2006.

Note: This filing does not provide data on revenue, profit, cash flow, operating margins, debt levels, or liquidity ratios.

Material Changes

The primary material change is the execution of a purchase agreement with underwriters (Merrill Lynch & Co., J.P. Morgan Securities Inc., and Credit Suisse Securities (USA) LLC) to sell equity. This represents a significant increase in outstanding shares and capital inflow for the company.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the sale is conducted under a shelf registration statement on Form S-3 (No. 333-131373).
Risks/Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard terms of the underwriting agreement and the potential exercise of the overallotment option.

Investor Verification Checklist

  • Verify the final number of shares sold, including whether the overallotment option was exercised.
  • Confirm the net proceeds received after deducting underwriting discounts and offering expenses.
  • Review the use of proceeds as detailed in the related prospectus or Form S-3.
  • Assess the dilution impact of the 7,000,000 new shares on existing shareholders.